CryoCell International Inc (CCEL)vsUniversal Health Services Inc (UHS)
CCEL
CryoCell International Inc
$3.99
-4.09%
HEALTHCARE · Cap: $35.48M
UHS
Universal Health Services Inc
$181.39
+1.17%
HEALTHCARE · Cap: $10.30B
Smart Verdict
WallStSmart Research — data-driven comparison
Universal Health Services Inc generates 58094% more annual revenue ($18.11B vs $31.13M). UHS leads profitability with a 8.4% profit margin vs -7.9%. UHS appears more attractively valued with a PEG of 1.19. UHS earns a higher WallStSmart Score of 72/100 (B).
CCEL
Buy50
out of 100
Grade: C-
UHS
Strong Buy72
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.9%
Fair Value
$5.05
Current Price
$3.99
$1.06 discount
Margin of Safety
-24.1%
Fair Value
$186.39
Current Price
$181.39
$5.00 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 129 in profit
Earnings expanding 72.1% YoY
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Reasonable price relative to book value
Every $100 of equity generates 20 in profit
Areas to Watch
Smaller company, higher risk/reward
Revenue declined 1.9%
Distress zone — elevated risk
Currently unprofitable
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : CCEL
The strongest argument for CCEL centers on Return on Equity, EPS Growth, Debt/Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.
Bull Case : UHS
The strongest argument for UHS centers on P/E Ratio, Price/Book, Return on Equity. PEG of 1.19 suggests the stock is reasonably priced for its growth.
Bear Case : CCEL
The primary concerns for CCEL are Market Cap, Revenue Growth, Altman Z-Score.
Bear Case : UHS
No major red flags identified for UHS, but monitor valuation.
Key Dynamics to Monitor
CCEL profiles as a turnaround stock while UHS is a value play — different risk/reward profiles.
UHS carries more volatility with a beta of 1.06 — expect wider price swings.
UHS is growing revenue faster at 8.3% — sustainability is the question.
UHS generates stronger free cash flow (216M), providing more financial flexibility.
Bottom Line
UHS scores higher overall (72/100 vs 50/100). CCEL offers better value entry with a 33.9% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CryoCell International Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.
Universal Health Services Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?